This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- Merck KGaA (MKGAY) to acquire Silence Therapeutics (SLN) for $20.00 per ADS in an all-cash deal valued at approximately $1.3 billion, representing a 130% premium to its last closing price.
- Microsoft (MSFT) has withdrawn from a major UK AI data center project with Nscale due to power grid delays, though it maintains its broader partnership with the Nvidia-backed startup.
- Intel (INTC) shares rose 4% in pre-market trading following a JPMorgan upgrade to Neutral, with analysts citing improved execution and rising demand for agentic AI workloads.
- Canada’s September CPI cooled more than expected to 3.1% (YoY), while core inflation measures remained steady, potentially influencing the Bank of Canada’s upcoming rate decision.
- Cleveland-Cliffs (CLF) shares surged 12% after reporting a third-quarter profit beat and issuing a strong $715 million EBITDA outlook for the next quarter.
Corporate M&A and Strategic Shifts
Merck KGaA (MKGAY) announced a definitive agreement to acquire Silence Therapeutics (SLN) for $20 per ADS in cash. The deal, valued at $1.3 billion, aims to bolster Merck’s rare disease pipeline with Silence’s siRNA (short interfering RNA) technology. The offer represents a massive 130% premium over the October 16 closing price, signaling intense competition for advanced genomic medicine assets.
Microsoft (MSFT) has canceled its anchor tenancy at a planned Nscale data center in Loughton, UK. The decision follows reports that the site would not receive a sufficient power connection until after 2030. Despite the exit from this specific site, Microsoft reaffirmed its commitment to the broader partnership with Nscale, which is currently preparing for a $35 billion New York IPO.
Semiconductor and Tech Momentum
Intel (INTC) received a significant sentiment boost as JPMorgan upgraded the stock to Neutral from Underweight. Analyst Harlan Sur noted that improved operational execution under CEO Lip-Bu Tan and the growth of CPU-intensive agentic AI are driving positive earnings revisions. The firm highlighted that the recent 36% pullback in Intel's share price has created a more balanced risk-reward profile for investors.
Skyworks Solutions (SWKS) gained 1.2% following positive mentions from activist investor Starboard Value. The firm believes Skyworks remains undervalued after its $22 billion acquisition of Qorvo. Starboard expects the merger to generate over $500 million in annual cost synergies and drive operating margins toward a 30%-35% target within three years.
Industrial and Healthcare Developments
Cleveland-Cliffs (CLF) reported third-quarter adjusted EPS of $0.28, beating the $0.22 analyst consensus. The steelmaker's stock jumped 12% as management projected a significant rise in fourth-quarter adjusted EBITDA to $715 million. The company's performance was bolstered by higher steel shipments totaling 4.2 million net tons and improved average selling prices.
Johnson & Johnson (JNJ) released new Phase 3 data for TREMFYA (guselkumab), showing it is the only IL-23 inhibitor to deliver durable fistula remission through 48 weeks in Crohn’s disease patients. The study showed remission rates increased to 35% by week 48, reinforcing the drug's competitive position in the high-stakes immunology market.
Global Macro and Geopolitical Alerts
Canada’s inflation data for September showed a headline increase of 3.1% (YoY), slightly below the 3.2% estimate. Monthly CPI rose just 0.1%, indicating a continued cooling of price pressures. This data provides the Bank of Canada with more flexibility as it prepares for its October 28 interest rate announcement.
In the Middle East, Saudi Civil Defense issued an emergency alert for the Najran region following a "hostile projectile" strike that injured six citizens. The escalating regional tensions have led several airlines, including Etihad, Qatar Airways, and Air India, to extend flight cancellations to Riyadh and other Saudi hubs through at least October 20.
Automated market updates written with AI from market data and news wire reports, published without human review.